Literature DB >> 31179300

Classification and differential diagnosis of Wilson's disease.

Wieland Hermann1.   

Abstract

Wilson's disease is characterized by hepatic and extrapyramidal movement disorders (EPS) with variable manifestation primarily between age 5 and 45. This variability often makes an early diagnosis difficult. A classification defines different clinical variants of Wilson's disease, which enables classifying the current clinical findings and making an early tentative diagnosis. Until the unequivocal proof or an autosomal recessive disorder of the hepatic copper transporter ATP7B has been ruled out, differential diagnoses have to be examined. Laboratory-chemical parameters of copper metabolism can both be deviations from the norm not related to the disease as well as other copper metabolism disorders besides Wilson's disease. In addition to known diseases such as Menkes disease, occipital horn syndrome (OHS), Indian childhood cirrhosis (ICC) and ceruloplasmin deficiency, recently discovered disorders are taken into account. These include MEDNIK syndrome, Huppke-Brendel syndrome and CCS chaperone deficiency. Another main focus is on differential diagnoses of childhood icterus correlated with age and anaemia as well as disorders of the extrapyramidal motor system. The Kayser-Fleischer ring (KFR) is qualified as classical ophthalmologic manifestation. The recently described manganese storage disease presents another rare metabolic disorder with symptoms similar to Wilson's disease. As this overview shows, Wilson's disease fits into a broad spectrum of internal and neurological disease patterns with icterus, anaemia and EPS.

Entities:  

Keywords:  ATPases; Wilson’s disease; classification; copper metabolism; icterus

Year:  2019        PMID: 31179300      PMCID: PMC6531651          DOI: 10.21037/atm.2019.02.07

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN: 2305-5839


  97 in total

Review 1.  Hepatic transport systems.

Authors:  Peter Ferenci; Gernot Zollner; Michael Trauner
Journal:  J Gastroenterol Hepatol       Date:  2002-02       Impact factor: 4.029

Review 2.  [Wilson's disease. The making of a diagnosis by conventional and molecular biology methods].

Authors:  T Maier-Dobersberger
Journal:  Dtsch Med Wochenschr       Date:  1999-04-23       Impact factor: 0.628

3.  Pigmented corneal rings in a patient with primary biliary cirrhosis.

Authors:  C R Fleming; E R Dickson; R W Hollenhorst; N P Goldstein; J T McCall; A H Baggenstoss
Journal:  Gastroenterology       Date:  1975-07       Impact factor: 22.682

Review 4.  Intracellular copper routing: the role of copper chaperones.

Authors:  M D Harrison; C E Jones; M Solioz; C T Dameron
Journal:  Trends Biochem Sci       Date:  2000-01       Impact factor: 13.807

5.  Interaction of the copper chaperone HAH1 with the Wilson disease protein is essential for copper homeostasis.

Authors:  I Hamza; M Schaefer; L W Klomp; J D Gitlin
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

6.  Copper-induced apical trafficking of ATP7B in polarized hepatoma cells provides a mechanism for biliary copper excretion.

Authors:  H Roelofsen; H Wolters; M J Van Luyn; N Miura; F Kuipers; R J Vonk
Journal:  Gastroenterology       Date:  2000-09       Impact factor: 22.682

7.  Functional properties of the copper-transporting ATPase ATP7B (the Wilson's disease protein) expressed in insect cells.

Authors:  Ruslan Tsivkovskii; John F Eisses; Jack H Kaplan; Svetlana Lutsenko
Journal:  J Biol Chem       Date:  2001-10-24       Impact factor: 5.157

Review 8.  Metabolic and molecular bases of Menkes disease and occipital horn syndrome.

Authors:  S G Kaler
Journal:  Pediatr Dev Pathol       Date:  1998 Jan-Feb

9.  Kufor-Rakeb syndrome, pallido-pyramidal degeneration with supranuclear upgaze paresis and dementia, maps to 1p36.

Authors:  D J Hampshire; E Roberts; Y Crow; J Bond; A Mubaidin; A L Wriekat; A Al-Din; C G Woods
Journal:  J Med Genet       Date:  2001-10       Impact factor: 6.318

10.  Differential alteration of the nigrostriatal dopaminergic system in Wilson's disease investigated with [123I]ss-CIT and high-resolution SPET.

Authors:  H Barthel; D Sorger; H J Kühn; A Wagner; R Kluge; W Hermann
Journal:  Eur J Nucl Med       Date:  2001-11
View more
  6 in total

1.  Wilson's Disease: Diagnosis of Wilson's Disease in Ethiopian Young Sisters.

Authors:  Nebiyu Bekele; Frew Ewnetu; Tigest Hailu; Zerubabel Tegegne; Abilo Tadesse
Journal:  Case Rep Med       Date:  2020-07-24

Review 2.  Therapeutic strategies in Wilson disease: pathophysiology and mode of action.

Authors:  Wolfgang Stremmel; Ralf Weiskirchen
Journal:  Ann Transl Med       Date:  2021-04

Review 3.  Are the new genetic tools for diagnosis of Wilson disease helpful in clinical practice?

Authors:  Carmen Espinós; Peter Ferenci
Journal:  JHEP Rep       Date:  2020-04-18

Review 4.  COMMD1 Exemplifies the Power of Inbred Dogs to Dissect Genetic Causes of Rare Copper-Related Disorders.

Authors:  Ronald Jan Corbee; Louis C Penning
Journal:  Animals (Basel)       Date:  2021-02-25       Impact factor: 2.752

Review 5.  Wilson disease and the differential diagnosis of its hepatic manifestations: a narrative review of clinical, laboratory, and liver histological features.

Authors:  Shannon M Schroeder; Karen E Matsukuma; Valentina Medici
Journal:  Ann Transl Med       Date:  2021-09

6.  A novel deep intronic variant in ATP7B in five unrelated families affected by Wilson disease.

Authors:  France Woimant; Aurelia Poujois; Adrien Bloch; Tabaras Jordi; Jean-Louis Laplanche; Hélène Morel; Corinne Collet
Journal:  Mol Genet Genomic Med       Date:  2020-08-08       Impact factor: 2.183

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.